GlassScriptPhysician profile
Alan Joseph
NPI 1942887856
$1,748.34
in general payments reported to CMS, 2019-2025
15 companies · $988 in 2025
The $988 reported for 2025 was more than what 88% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $409 · 2023: $168 · 2024: $182 · 2025: $988.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,339.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,339.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Penumbra, INC. | $296.88 | 2025 | Indigo System |
| Philips North America LLC | $223.60 | 2024-2025 | Encore, (5044) Mcot |
| Genzyme Corporation | $201.60 | 2022 | |
| Inari Medical, INC. | $177.59 | 2025 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Shockwave Medical, INC | $161.40 | 2025 | |
| Abbvie INC. | $125.00 | 2022 | |
| Cardiva Medical, INC. | $117.88 | 2023 | Cardiva Vascade 6/7f Vcs |
| Edwards Lifesciences Corporation | $96.58 | 2024-2025 | Sapien 3 Ultra Resilia, Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Medtronic, INC. | $91.11 | 2025 | Pulseselect, Symplicity G3, Venaseal |
| E.R. Squibb & Sons, L.L.C. | $82.68 | 2022 | |
| Kestra Medical Technology Services, INC. | $51.51 | 2025 | Assure Wcd |
| Pfizer INC. | $50.34 | 2023 | |
| Abiomed | $37.62 | 2025 | |
| Merck Sharp & Dohme LLC | $17.44 | 2024 | Verquvo |
| Janssen Pharmaceuticals, INC | $17.11 | 2024 | Xarelto |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alan Joseph listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.